RxDoctor Payments Data

Joanne Combs

Nurse Practitioner · Booneville, KYNPI 1932652096

Payments from drug & device makers

$907in general payments, 2019–2025

Across 47 payments — averaging $19.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$280
  • Indivior Inc.$200
  • Orexo US, Inc.$56
  • Alkermes, Inc.$52
  • Pfizer$48
  • Braeburn Inc.$47
  • plus $225 from 7 others

What the payments were for

  • Food & beverage$86595%
  • Education$425%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$907 in reported general payments places this provider in the 65th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$6,564
Medicare patients
36
Services billed
120

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide51$49,391
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl405$45,854
FarxigaDapagliflozin Propanediol50$41,619
TrulicityDulaglutide29$32,784
MounjaroTirzepatide22$23,224
Combivent RespimatIpratropium/Albuterol Sulfate26$21,078
OzempicSemaglutide18$16,643
EliquisApixaban18$13,894
JanuviaSitagliptin Phosphate24$13,131
JardianceEmpagliflozin19$11,759
TradjentaLinagliptin11$9,428
EntrestoSacubitril/Valsartan11$7,177
Ondansetron Hcl36$6,695
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen341$5,990
Ventolin HfaAlbuterol Sulfate78$5,357

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$15$56,00951 claims
AbbVieLinzess, Synthroid$280$50,11165 claims
Hikma Pharmaceuticals USABuprenorphine-Naloxone, Buprenorphine Hcl$42$47,371454 claims
PfizerEliquis$48$13,89418 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Booneville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →